Compounds > medroxyprogesterone

Page last updated: 2024-08-21

medroxyprogesterone and Malignant Melanoma

medroxyprogesterone has been researched along with Malignant Melanoma in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anderson, T; Eisenstein, N; Eisenstein, R; Harper, E; Hsiao, K; Lemke, M; Schumacher, B	1
Diokno, AC; McDonald, MW; Menon, KM; Seski, JC	1
Becher, R; Bojar, H; Höffken, K; Kloke, O; Scheulen, ME; Schmidt, CG; Wandl, UB	1
Mouridsen, HT; Pedersen, L; Rose, C	1
Ahlesteen, I; Astedt, B; Kjaeldgaard, A; Larsson, B	1
Lusk, W; Sadoff, L	1

Other Studies

6 other study(ies) available for medroxyprogesterone and Malignant Melanoma

Article	Year
Effect of medroxyprogesterone and an aorta-derived cell growth inhibitor on B16 melanoma in mice. Journal of the National Cancer Institute, 1984, Volume: 72, Issue:4 Topics: Animals; Aorta; Cell Line; Combined Modality Therapy; Evaluation Studies as Topic; Growth Inhibitors; Lung Neoplasms; Male; Medroxyprogesterone; Melanoma; Mice; Microbial Collagenase; Neoplasm Transplantation; Time Factors; Tissue Extracts	1984
Measurement of progesterone receptor in human renal cell carcinoma and normal renal tissue. Journal of surgical oncology, 1983, Volume: 22, Issue:3 Topics: Adenocarcinoma; Female; Humans; Kidney; Kidney Neoplasms; Male; Medroxyprogesterone; Melanoma; Nephrectomy; Receptors, Progesterone; Vaginal Neoplasms	1983
Phase II study of high-dose medroxyprogesterone acetate in advanced malignant melanoma. British journal of cancer, 1989, Volume: 59, Issue:6 Topics: Antineoplastic Agents; Drug Evaluation; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Melanoma	1989
Endocrine treatment with anti-estrogen, anti-androgen or progestagen of advanced malignant melanoma: three consecutive phase II trials. European journal of cancer & clinical oncology, 1985, Volume: 21, Issue:10 Topics: Adult; Aged; Androgen Antagonists; Antineoplastic Agents; Cyproterone; Cyproterone Acetate; Female; Hormone Antagonists; Humans; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Melanoma; Middle Aged; Progestins; Tamoxifen	1985
Progestogen regulation of tissue plasminogen activator in a human melanoma cell line. Thrombosis research, 1988, Jan-15, Volume: 49, Issue:2 Topics: Ethanol; Fibrinolysis; Humans; Levonorgestrel; Medroxyprogesterone; Melanoma; Norethindrone; Norgestrel; Osmolar Concentration; Time Factors; Tissue Plasminogen Activator; Tumor Cells, Cultured	1988
The effect of large doses of medroxyprogesterone acetate (MPA) on urinary estrogen levels and serum levels of cortisol T4 LH and testosterone in patients with advanced cancer. Obstetrics and gynecology, 1974, Volume: 43, Issue:2 Topics: Adrenocorticotropic Hormone; Adult; Aged; Breast Neoplasms; Dose-Response Relationship, Drug; Estrogens; Female; Humans; Hydrocortisone; Injections, Intramuscular; Kidney Neoplasms; Luteinizing Hormone; Male; Medroxyprogesterone; Melanoma; Middle Aged; Neoplasms; Pituitary-Adrenal System; Testosterone; Thyroid Gland; Thyroxine	1974